$4.8 billion deal for gene therapy pioneer Spark Therapeutics delayed once more
June 10, 2019 at 10:09 AM EDT
With more questions coming from the FTC, Roche has extended the deadline of its tender offer for a fourth time.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|